GlassScriptPhysician profile
Som Nath Chalise
NPI 1255580361
$5,938.40
in general payments reported to CMS, 2019-2025
26 companies · $21.13 in 2025
The $21.13 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,993 · 2020: $396 · 2021: $312 · 2022: $17.31 · 2023: $1,670 · 2024: $1,529 · 2025: $21.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $1,016 · Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $1,015.60 |
| Food and Beverage | $704.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,596.89 | 2023-2024 | Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $468.18 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $439.25 | 2019-2023 | Fasenra |
| Genentech USA, INC. | $325.19 | 2019 | |
| Glaxosmithkline, LLC. | $301.96 | 2019-2023 | Nucala |
| Sunovion Pharmaceuticals INC. | $212.25 | 2019 | |
| Inari Medical, INC. | $193.75 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Mylan Specialty L.P. | $143.30 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $141.51 | 2019-2021 | |
| Livanova USA, INC. | $128.24 | 2023 | Lifesparc |
| Regeneron Healthcare Solutions, INC. | $126.64 | 2019 | |
| Mallinckrodt Enterprises LLC | $124.61 | 2019 | |
| Grifols USA, LLC | $106.29 | 2019 | |
| Getinge USA Sales, LLC | $102.20 | 2023 | Cardiohelp |
| Novartis Pharmaceuticals Corporation | $94.27 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $88.79 | 2019 | |
| Philips North America LLC | $67.02 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $62.94 | 2019-2025 | Winrevair |
| Insmed, INC. | $37.78 | 2019 | |
| Inspire Medical Systems, INC. | $34.37 | 2023 | Inspire |
| Paratek Pharmaceuticals, INC. | $33.16 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.11 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $22.71 | 2020 | |
| Breathe Technologies, INC. | $21.50 | 2019 | |
| Advanced Respiratory, INC | $20.66 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Som Chalise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.